3 Stocks Pushing The Health Services Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 81 points (0.5%) at 17,082 as of Monday, Aug. 25, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,780 issues advancing vs. 1,159 declining with 188 unchanged.

The Health Services industry currently sits up 0.4% versus the S&P 500, which is up 0.4%. A company within the industry that fell today was Community Health Systems ( CYH), up 1.5%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.0%, Grifols ( GRFS), up 1.0%, Stryker Corporation ( SYK), up 0.9% and UnitedHealth Group ( UNH), up 0.7%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Tenet Healthcare ( THC) is one of the companies pushing the Health Services industry lower today. As of noon trading, Tenet Healthcare is down $0.97 (-1.6%) to $59.62 on light volume. Thus far, 463,184 shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $59.40-$60.58 after having opened the day at $60.49 as compared to the previous trading day's close of $60.59.

Tenet Healthcare Corporation, an investor-owned health care services company, primarily operates acute care hospitals and related health care facilities in the United States. Tenet Healthcare has a market cap of $5.9 billion and is part of the health care sector. Shares are up 43.9% year-to-date as of the close of trading on Friday. Currently there are 9 analysts that rate Tenet Healthcare a buy, 1 analyst rates it a sell, and 6 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including generally higher debt management risk and poor profit margins. Get the full Tenet Healthcare Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, HCA Holdings ( HCA) is down $0.58 (-0.8%) to $68.68 on light volume. Thus far, 746,646 shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.3 million shares. The stock has ranged in price between $68.53-$69.72 after having opened the day at $69.36 as compared to the previous trading day's close of $69.26.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $29.6 billion and is part of the health care sector. Shares are up 45.2% year-to-date as of the close of trading on Friday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, good cash flow from operations and growth in earnings per share. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Covidien ( COV) is down $0.71 (-0.8%) to $87.55 on light volume. Thus far, 1.5 million shares of Covidien exchanged hands as compared to its average daily volume of 5.9 million shares. The stock has ranged in price between $87.50-$88.68 after having opened the day at $88.59 as compared to the previous trading day's close of $88.26.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $40.2 billion and is part of the health care sector. Shares are up 29.6% year-to-date as of the close of trading on Friday. Currently there are 8 analysts that rate Covidien a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Covidien Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing